Boston Scientific Warns Of More Defibrillator Problems

Law360, New York (July 23, 2010, 4:17 PM EDT) -- Boston Scientific Corp. is warning physicians about a possible defect in switch mechanisms for three of its implantable cardioverter defibrillators that may cause the devices to fail to deliver needed electric stimulation to patients’ hearts.

The Natick, Mass.-based company announced Thursday that it sent an advisory letter to doctors detailing the potential switch performance problems with Contak Renewal 3, Contak Renewal 4 and Vitality HE devices that were manufactured between January 2006 and November 2007.

The defect at issue relates to so-called “magnetic reed switches,” which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.